Todd Franklin Watanabe Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Todd Franklin Watanabe is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 823,430 shares of ARQT, which is worth approximately $12.3 Million. The most recent transaction as insider was on Dec 20, 2024, when has been sold 15,000 shares (Common Stock) at a price of $15.17 per share, resulting in proceeds of $227,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 823K
2.7% 3M change
64.02% 12M change
Total Value Held $12.3 Million

Todd Franklin Watanabe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2024
SELL
Open market or private sale
$227,550 $15.17 p/Share
15,000 Reduced 1.79%
823,430 Common Stock
Nov 30 2024
BUY
Open market or private purchase
$14,490 $7.11 p/Share
2,038 Added 0.24%
838,430 Common Stock
Nov 04 2024
SELL
Open market or private sale
$120,400 $8.68 p/Share
13,871 Reduced 1.64%
832,392 Common Stock
Aug 02 2024
SELL
Open market or private sale
$130,672 $9.02 p/Share
14,487 Reduced 1.68%
846,263 Common Stock
May 31 2024
BUY
Open market or private purchase
$6,760 $1.69 p/Share
4,000 Added 0.48%
836,392 Common Stock
May 02 2024
SELL
Open market or private sale
$120,463 $8.74 p/Share
13,783 Reduced 1.58%
860,750 Common Stock
Mar 04 2024
SELL
Open market or private sale
$165,721 $11.12 p/Share
14,903 Reduced 1.68%
874,533 Common Stock
Feb 28 2024
SELL
Open market or private sale
$26,129 $10.6 p/Share
2,465 Reduced 0.28%
889,436 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
264,882 Added 22.9%
891,901 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
125,000 Added 16.62%
627,019 Common Stock
Dec 20 2023
SELL
Bona fide gift
-
13,126 Reduced 2.55%
502,019 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
$100,002 $1.68 p/Share
59,525 Added 10.38%
513,682 Common Stock
May 31 2023
BUY
Open market or private purchase
$9,333 $6.38 p/Share
1,463 Added 0.28%
515,145 Common Stock
Mar 06 2023
SELL
Open market or private sale
$37,158 $15.26 p/Share
2,435 Reduced 0.66%
366,657 Common Stock
Mar 02 2023
SELL
Open market or private sale
$88,482 $16.17 p/Share
5,472 Reduced 1.46%
369,092 Common Stock
Feb 28 2023
SELL
Open market or private sale
$37,886 $16.17 p/Share
2,343 Reduced 0.62%
374,564 Common Stock
Feb 14 2023
SELL
Open market or private sale
$8,804 $17.03 p/Share
517 Reduced 0.14%
376,907 Common Stock
Feb 13 2023
SELL
Open market or private sale
$8,215 $17.01 p/Share
483 Reduced 0.13%
377,424 Common Stock
Feb 01 2023
SELL
Open market or private sale
$17,000 $17.0 p/Share
1,000 Reduced 0.26%
377,907 Common Stock
Dec 07 2022
SELL
Open market or private sale
$17,060 $17.06 p/Share
1,000 Reduced 0.26%
378,907 Common Stock
Nov 07 2022
SELL
Open market or private sale
$18,000 $18.0 p/Share
1,000 Reduced 0.26%
379,907 Common Stock
Oct 07 2022
SELL
Open market or private sale
$19,510 $19.51 p/Share
1,000 Reduced 0.26%
380,907 Common Stock
Sep 07 2022
SELL
Open market or private sale
$21,510 $21.51 p/Share
1,000 Reduced 0.26%
381,907 Common Stock
Aug 05 2022
SELL
Open market or private sale
$61,850 $24.74 p/Share
2,500 Reduced 0.38%
651,871 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
$4,200 $1.68 p/Share
2,500 Added 0.38%
654,371 Common Stock
TFW

Todd Franklin Watanabe

Director
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT